TEERDendrite Clinical SystemsMRmitral regurgitation
…in table 1 and MR aetiology is shown in Abstract 80 Figure 1. A TEER device was successfully implanted in 92 (93%) patients. The Abb…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 541–600 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Locoregional therapy3Pancreatic Enzyme Replacement Therapy3Peroral endoscopic myotomy3Pharmacologic treatment3Positive Airway Pressure (PAP) therapy3Regional analgesia3Traditional Chinese Medicine3Vitamin supplementation3advanced therapies3anti-PD1 therapy3anti-VEGF therapy3anti-programmed cell death protein-1 therapy3antiarrhythmic therapy3anticancer therapies3anticancer therapy3autologous stem cell transplantation3behavioural therapy3cancer therapies3chimeric antigen receptor T-cell therapy3clinical management3cognitive–behavioural therapy3conventional immunosuppression3coronary revascularisation3deworming3diabetes treatment3dopaminergic therapy3haematopoietic stem cell transplantation3immunotherapy treatment3inhaled corticosteroids3intensive care treatment3intravenous fluid therapy3intravenous iron therapy3lethal palliation3lifestyle changes3local anaesthesia3neurocritical care3novel therapies3nutritional support3occupational therapy3oral antibiotics3outpatient treatment3palliative chemotherapy3pharmacological interventions3physical rehabilitation3preventive measures3standard therapy3standard treatment3stent retriever thrombectomy3supportive treatment3surgical interventions3surgical management3symptomatic therapy3targeted treatment3topical therapy3tracheostomy3tyrosine kinase inhibitors3ultrasound-guided nerve blocks3vasodilator therapy3vasopressors3ventriculoperitoneal shunting3
Articles mentioning treatments
7,227 articles · page 17 of 603venesectionLTFUHCChaemochromatosishaemochromatosis-specificH63DNHS Blood and TransplantC282Y
…pandemic. The remaining 120 patients were engaging with regular venesection.34% patients had no available liver ultrasound.2 patients had a…
Liver transplantLTChronic liver disease (CLD)
… first 60 days following index first emergency admission (FEA). Liver transplant (LT) is the only intervention with survival benefit in advanced…
RMTRTX-containing induction therapySLE-TTPSLE
…d in high rates of clinical remission in patients with SLE-TTP. RMT was associated with a significantly reduced risk of TTP relapse…
lung transplantationdouble lung transplantationsingle lung transplantationdouble lung transplantssilicosiscrystalline silica
… the increased use of artificial stone. In end-stage silicosis, lung transplantation may be the only available treatment. While double lung transpla…
EVTEndovascular treatmentvertebrobasilar artery occlusion (VBAO)VBAO
…ith pc-ASPECTS <6 and to identify patients who may benefit from EVT.…
acupunctureketorolacondansetronmidazolamfamotidineketaminedexamethasonepropofol
…exploring potential effectiveness of non-opioid approaches like acupuncture in treating post-operative pain should be prioritized.Methods T…
interscalene blockISBPBneuromodulationlow-volume superior trunk blockNumeric Rating Scaleoxycodonecodeinechronic painPRN oral morphinephrenic nerve blockade
…ents undergoing major total shoulder arthroplasty often receive interscalene block (ISBPB) for pain management. However, it carries a risk of phre…
parasternal blockRectus sheath blocklocal anestheticNCT05764616cardiac surgery
…otomy pain, with possible adverse effects on outcome. While the parasternal block can improve analgesia, its coverage may be insufficient to cove…
Triple therapyevolocumabezetimibeAISlarge vessel occlusion (LVO)acute ischemic stroke
…group showed significantly lower mean cholesterol and TG level. Triple therapy group showed a lower discharge NIHSS (2.7 ± 2.2 vs. 5.5 ± 6.9, …
ChemotherapyRadiotherapyLung cancerBarclay et al
…s substantial variation in treatment use between jurisdictions. Chemotherapy use ranged from 23% in Northern Ireland to 45% in Norway, while…